Drug Trial Radar · NCT00530348
Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One
Last checked: Nov 20, 2026Latest source record: Nov 24, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
581
Actual
Start
Aug 2007
Primary completion
Apr 2011
Study completion Apr 2011
Sponsor
- Lead sponsor
- Genzyme, a Sanofi CompanySanofi (SNY)
- Sponsor type
- Industry
- Collaborators
- Bayer
- First posted
- Sep 17, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study was to establish the efficacy and safety of alemtuzumab (Lemtrada™) as a treatment for relapsing-remitting multiple sclerosis (MS), in comparison with subcutaneous (SC) interferon beta-1a (Rebif®). The study had enrolled participants who had not previously received MS disease-modifying therapies. Participants had monthly laboratory tests and comprehensive testing every 3 months.
Conditions
- Multiple Sclerosis, Relapsing-Remitting
Interventions
AlemtuzumabBiological
Alemtuzumab 12 milligram (mg) per day intravenous (IV) infusion on 5 consecutive days at Month 0, followed by alemtuzumab 12 mg per day IV infusion on 3 consecutive days at Month 12.
Interferon beta-1aBiological
Interferon beta-1a 44 microgram (mcg) subcutaneously 3-times weekly for 24 months. Dose adjustment was done as per Investigator's discretion.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Sustained Accumulation of Disability (SAD)Time frame: Up to 2 years
- Annualized Relapse RateTime frame: Up to 2 years
Locations
101 sites in 16 countries. Site status is shown where the registry gives one.
North Central Neurology Associates, P.C.
Cullman, Alabama
Barrow Neurological Institute, St. Joseph's Hospital & Medical Center
Phoenix, Arizona
Mayo Clinic Arizona
Scottsdale, Arizona
Northwest NeuroSpecialists, PLLC
Tucson, Arizona
Advanced Neurosciences Research
Fort Collins, Colorado
Neurological Associates
Pompano Beach, Florida
Axiom Clinical Research of Florida
Tampa, Florida
Idaho Falls Multiple Sclerosis Center, PLLC
Idaho Falls, Idaho
Consultants in Neurology, Ltd.
Northbrook, Illinois
Fort Wayne Neurological Center
Fort Wayne, Indiana
University of Kansas Medical Center
Kansas City, Kansas
MidAmerican Neuroscience Institute
Lenexa, Kansas
Associates in Neurology, PSC
Lexington, Kentucky
University of Louisville Research Foundation
Louisville, Kentucky
Louisiana State University Health Sciences Center
Shreveport, Louisiana
UMass Memorial Medical Center
Worcester, Massachusetts
University of Michigan Health System
Ann Arbor, Michigan
Wayne State University
Detroit, Michigan
University of Nevada School of Medicine
Las Vegas, Nevada
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
University of New Mexico, Health Sciences Center, MS Specialty Clinic
Albuquerque, New Mexico
Empire Neurology
Latham, New York
Comprehensive Multiple Sclerosis Care Center at South Shore Neurologic Associates, P.C.
Patchogue, New York
University of Rochester Medical Center
Rochester, New York
Carolinas Medical Center (CMC), Neurosciences & Spine Institute (NSSI)
Charlotte, North Carolina
The Ohio State University Medical Center, Multiple Sclerosis Center
Columbus, Ohio
Oak Clinic for Multiple Sclerosis
Uniontown, Ohio
MS Center of Oklahoma
Oklahoma City, Oklahoma
Lehigh Valley Hospital Neurosciences and Pain Research
Allentown, Pennsylvania
Advanced Neurosciences Institute
Franklin, Tennessee
Biomedical Research Alliance of NY, LLC
Franklin, Tennessee
Hope Neurology PC
Knoxville, Tennessee
Baylor College of Medicine, Maxine Mesinger MS Clinic
Houston, Texas
Central Texas Neurology
Round Rock, Texas
Integra Clinical Research
San Antonio, Texas
Neurology Center of San Antonio
San Antonio, Texas
DIABAID
Buenos Aires, Argentina
Concord Repatriation General Hospital
Concord, Australia
Westmead Hospital
Westmead, Australia
The Wesley Research Institute
Auchenflower, Queensland, Australia
Showing 40 of 101 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.